glp-1 drug updates Safety Check GLP-1 Drugs from the Gray

So I would say Im cautiously experimenting with it, but so far I love it

Motus reported about a 10.4 percent average weight loss in human clinical trials over six months which is exceptional for a supplement and positions it strongly among oral approaches

If timing precision feels overwhelming or your schedule makes consistent administration genuinely impossible, evening dosing (810 PM) offers the most forgiving window

This is about working smarter, not just harder

Increased baseline IL-17 concentrations were temporally associated with subsequent development of ICI-associated colitis (65)

Which forms and doses did trials use